ClinicalTrials.govpublic full text
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
multiple myeloma, myeloma, relapsed multiple myeloma, refractory multiple myeloma, pf-06863135, bcma, bispecific, bispecific antibody, bcma-cd3 bispecific, elranatamab, magnetismm-3, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 876937
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.